Cancer Outcomes Archives - Page 18 of 23

UNC Lineberger’s Lawrence Marks, MD, is chair of the radiation oncology department and the Dr. Sidney K. Simon Distinguished Professor of Oncology Research.

Nearly 30 UNC Lineberger studies were featured at the American Society for Radiation Oncology’s 2017 Annual Meeting was held in San Diego Sept. 24-27.

(Left to right) Stacie Dusetzina, PhD, Ashley Cole, MPH, and Hannah Sanoff, MD, MPH

A study led by UNC Lineberger's Stacie Dusetzina, PhD, compared the cost of the generic and brand-name version of capecitabine, which was one of the first high-priced chemotherapy pills to come off patent in the United States. Their findings offer a glimpse into what could be happening with generic competition in this specialty drug market.

Academics and policymakers are using the Cancer Information & Population Health Resource, or CIPHR, to knit together data from multiple public and private sources to examine a wide range of complex issues tied to improving cancer outcomes in North Carolina.

UNC Lineberger's Donald Rosenstein, MD, director of the UNC Comprehensive Cancer Support Program, was elected to lead the American Psychosocial Oncology Society.

Daniel S. Reuland, MD, MPH, Stephanie Wheeler, PhD, MPH, and Alison Brenner, PhD, MPH, of UNC Lineberger's Carolina Cancer Screening Initiative

The Carolina Cancer Screening Initiative, led by Daniel S. Reuland, MD, MPH, brings together UNC Lineberger’s clinicians and public health researchers with community partners to implement evidence-based cancer screening programs to reduce cancer burden among North Carolinians.

Hyman B. Muss, MD, (front row, second from the right) was one of 11 healthcare professionals who was recognized for advancing the field of oncology through research and clinical practice.

Hyman B. Muss, MD, was honored at a ceremony in Chicago for his contributions that have advanced the fields of supportive, palliative and geriatric cancer care.

Ethan Basch, MD, MSc, director of the UNC Lineberger Cancer Outcomes Research Program, presented findings from a new study in a plenary session at the ASCO Annual Meeting.

Research presented by UNC Lineberger members was featured in plenary and other major sessions of the meeting this year, and was picked up by multiple media outlets.

At the 2017 American Society of Clinical Oncology Annual Meeting in Chicago, UNC Lineberger researchers led by Hyman B. Muss, MD, presented preliminary findings from several studies focused on older adults with cancer.

Ronald C. Chen, MD, MPH, is an associate professor in the UNC School of Medicine Department of Radiation Oncology and study’s senior author.

UNC Lineberger researchers led by Ronald C. Chen, MD, MPH, surveyed 1,171 men diagnosed with prostate cancer in North Carolina, finding that while both white and black men were concerned about curing their cancer and the quality-of-life impacts of treatment, more black men considered other social and personal factors -- such as recovery time and cost -- to be very important in their treatment decision-making.

A study presented by Ethan Basch, MD, MSc, at the American Society of Clinical Oncology is the first to find a survival benefit for patient reported outcomes.

Tag: Cancer Outcomes

Radiation oncology researchers present at ASTRO

Savings less than expected for generic oral chemotherapy

Innovative cancer data resource expands, gains a new name

Rosenstein elected head of national psychosocial oncology society

UNC Lineberger program focused on improving screening rates, reducing cancer deaths

Muss named a ‘Giant of Cancer Care’

UNC Lineberger research featured at ASCO Annual Meeting

Researchers strive to improve cancer care for older patients

Black, white men view impacts of prostate cancer treatment differently, study finds

Cancer patients who systematically reported their symptoms lived longer